1-Ethylquinolonium

1-Ethylquinolonium

SCHEMBL29623615

CC[n+]1cccc2ccccc21.C[n+]1cccc2ccccc21

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.53
BCHE P06276 12/20 0.53
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
RGS12 O14924 1/20 0.51
NPC1 O15118 1/20 0.51
USP2 O75604 1/20 0.51
LMNA P02545 1/20 0.51
HSP90AA1 P07900 1/20 0.51
THRB P10828 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAD52 P43351 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
MCL1 Q07820 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Ethylquinolonium SCHEMBL309459 0.90 ACHE (0.63) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL9135771 0.88 ACHE (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL30920082 0.88 KDM4E (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL10655763 0.88 ACHE (0.64) ACHEBCHE
1-Ethylquinolonium SCHEMBL186988 0.88 KDM4E (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL18804795 0.88 ACHE (0.61) ACHEBCHEKDM4EMEN1RGS12
SCHEMBL307903 0.84 ACHE (0.53) ACHEBCHE
SCHEMBL29752612 0.84 ACHE (0.53) ACHEBCHE
1-Ethylquinolonium SCHEMBL4624855 0.83 ACHE (0.55) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL28221155 0.83 ACHE (0.55) ACHEBCHEKDM4EMEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733152-B1 POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION SHOFU INC (JP) 2026-03-11 EP disclosed
US-11478408-B2 Two-paste type dental resin-reinforced glass ionomer cement composition SHOFU INC. (JP) 2022-10-25 US disclosed
US-11324669-B2 Powder-liquid type dental resin-reinforced glass ionomer cement composition SHOFU INC. (JP) 2022-05-10 US disclosed
EP-3733153-B1 TWO-PASTE TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION SHOFU INC (JP) 2022-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11478408-B2 Two-paste type dental resin-reinforced glass ionomer cement composition ARID2, TAS2R42, MMAB ACHE 4132/4885BCHE 4472/4885KDM4E 792/4885
US-11324669-B2 Powder-liquid type dental resin-reinforced glass ionomer cement composition WDR1, WDR91, ARID2 ACHE 4361/4885BCHE 4568/4885KDM4E 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.